When Evidence Falls Short—Belzutifan for Treating Tumours Associated with von Hippel-Lindau Disease: An External Assessment Group Perspective on a NICE Single Technology Appraisal

Isaac Corro Ramos; Susan O’Meara; Mubarak Patel; Lisa Stirk; Jiongyu Chen; Xiaoyu Tian; Nigel Armstrong

doi:10.1007/s40273-025-01505-z

When Evidence Falls Short—Belzutifan for Treating Tumours Associated with von Hippel-Lindau Disease: An External Assessment Group Perspective on a NICE Single Technology Appraisal

Isaac Corro Ramos^*
, Susan O’Meara
, Mubarak Patel
, Lisa Stirk
, Jiongyu Chen
, Xiaoyu Tian
, Nigel Armstrong

^*Corresponding author for this work

Health Services Management Centre

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	PharmacoEconomics
Early online date	7 May 2025
DOIs	https://doi.org/10.1007/s40273-025-01505-z
Publication status	E-pub ahead of print - 7 May 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Pharmacology
Health Policy
Public Health, Environmental and Occupational Health

Access to Document

10.1007/s40273-025-01505-zLicence: Creative Commons: Attribution-NonCommercial (CC BY-NC)

Cite this

Corro Ramos, I., O’Meara, S., Patel, M., Stirk, L., Chen, J., Tian, X., & Armstrong, N. (2025). When Evidence Falls Short—Belzutifan for Treating Tumours Associated with von Hippel-Lindau Disease: An External Assessment Group Perspective on a NICE Single Technology Appraisal. PharmacoEconomics. Advance online publication. https://doi.org/10.1007/s40273-025-01505-z

@article{f90ed0189e51408baa65f66b6279ab60,

title = "When Evidence Falls Short—Belzutifan for Treating Tumours Associated with von Hippel-Lindau Disease: An External Assessment Group Perspective on a NICE Single Technology Appraisal",

author = "\{Corro Ramos\}, Isaac and Susan O{\textquoteright}Meara and Mubarak Patel and Lisa Stirk and Jiongyu Chen and Xiaoyu Tian and Nigel Armstrong",

year = "2025",

month = may,

day = "7",

doi = "10.1007/s40273-025-01505-z",

language = "English",

journal = "PharmacoEconomics",

issn = "1170-7690",

publisher = "Springer",

}

TY - JOUR

T1 - When Evidence Falls Short—Belzutifan for Treating Tumours Associated with von Hippel-Lindau Disease

T2 - An External Assessment Group Perspective on a NICE Single Technology Appraisal

AU - Corro Ramos, Isaac

AU - O’Meara, Susan

AU - Patel, Mubarak

AU - Stirk, Lisa

AU - Chen, Jiongyu

AU - Tian, Xiaoyu

AU - Armstrong, Nigel

PY - 2025/5/7

Y1 - 2025/5/7

UR - https://www.scopus.com/pages/publications/105004477719

U2 - 10.1007/s40273-025-01505-z

DO - 10.1007/s40273-025-01505-z

M3 - Article

AN - SCOPUS:105004477719

SN - 1170-7690

JO - PharmacoEconomics

JF - PharmacoEconomics

ER -